News

Vedanta opens manufacturing facility to produce lead candidate as it heads for PhIII

Vedanta opens manufacturing facility to produce lead candidate as it heads for PhIII

Endpoints | The microbiome startup Vedanta, while still forging ahead with the Phase III process for its Clostridioides difficile infection candidate, has completed a manufacturing facility to produce the drug.

 

Full Story